2023
DOI: 10.1152/ajprenal.00285.2022
|View full text |Cite
|
Sign up to set email alerts
|

The urinary proteome infers dysregulation of mitochondrial, lysosomal, and protein reabsorption processes in chronic kidney disease of unknown etiology (CKDu)

Abstract: Chronic kidney disease of uncertain etiology (CKDu) is a global health concern affecting tropical farming communities. CKDu is not associated with typical risk factors (e.g., diabetes) and strongly correlates with environmental drivers. To gain potential insights into disease etiology and diagnosis, here we report the first urinary proteome comparing CKDu patients and non-CKDu controls from Sri Lanka. We found 944 differentially abundant proteins (DAPs). In silico analyses identified 636 proteins of likely kid… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

1
3
0

Year Published

2023
2023
2024
2024

Publication Types

Select...
5
2

Relationship

1
6

Authors

Journals

citations
Cited by 8 publications
(5 citation statements)
references
References 96 publications
1
3
0
Order By: Relevance
“…Importantly, Kolli et al recently were the first to publish on the urinary proteome of CKDu/CINAC patients, reporting findings similar to ours, e.g. roles of mitochondrial, lysosomal, and protein reabsorption processes in disease onset and progression of CINAC 59 .…”
Section: Discussionsupporting
confidence: 83%
“…Importantly, Kolli et al recently were the first to publish on the urinary proteome of CKDu/CINAC patients, reporting findings similar to ours, e.g. roles of mitochondrial, lysosomal, and protein reabsorption processes in disease onset and progression of CINAC 59 .…”
Section: Discussionsupporting
confidence: 83%
“…Ten or 11 μLs of peptide digest (∼33 μg from batch 1 and ∼36 μg from batch 2) were analyzed by microflow liquid chromatography (LC) coupled to tandem mass spectrometry (MS/MS) using data-independent acquisition (DIA) as previously described. 56 Briefly, LC used an ACQUITY LC (Waters) with a 1 × 100 mm, 1.7 μm ACQUITY Premier CSH C18 column using a flow rate of 100 μL/min, a column temperature of 55 °C, and a gradient of 3−28% (v/v) MeCN/ H 2 O with 0.1% formic acid over 60 min. DMSO was delivered postcolumn 57,58 using an M-Class Auxiliary Solvent Manager (Waters) delivering 50/50 (v/v) MeCN/DMSO at a flow rate of 6 μL/min via a PEEK mixing tee (Valco).…”
Section: Mass Spectrometry-based Plasma Proteomicsmentioning
confidence: 99%
“…Biomarkers such as kidney injury molecule (KIM)-1, neutrophil gelatinase-associated lipocalin (NGAL) and so forth, can potentially identify renal injury earlier than conventional markers such as creatinine; however, their use has not been validated yet [97,98]. Recently, a potential role of urinary proteome profiling for early diagnosis of CKDu has been suggested [99].…”
Section: Secondary and Tertiary Preventionmentioning
confidence: 99%